Bristol Myers Squibb (BMY) is a publicly traded Healthcare sector company. As of October 3, 2026, BMY trades at $61.05 with a market cap of $125.55B and a P/E ratio of 13.78. BMY moved -0.72% today. Year to date, BMY is +14.38%; over the trailing twelve months it is +33.72%. Its 52-week range spans $42.52 to $68.64. Analyst consensus is buy with an average price target of $67.22. Rallies surfaces BMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BMY combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $61.05 |
| Market Cap | $125.55B |
| P/E Ratio | 13.78 |
| EPS | $4.56 |
| Dividend Yield | 0.63% |
| 52-Week High | $68.64 |
| 52-Week Low | $42.52 |
| Volume | 5.62M |
| Avg Volume | 0 |
| Revenue (TTM) | $49.19B |
| Net Income | $9.27B |
| Gross Margin | 70.16% |
20 analysts cover BMY: 0 strong buy, 8 buy, 11 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $67.22.